NCT02713542

Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Arthrex, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This study is primarily investigating the effectiveness of Autologous Conditioned Plasma (ACP) Intra-articular (IA) in patients with Osteoarthritis (OA) in the knee.

Detailed description

This study is a prospective, multi center randomized double blind, two arm study. 90 subjects will be randomized to receive injections of either Autologous Conditioned Plasma Intra-articular or the control.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DEVICE	ACP	Autologous Conditioned Plasma
OTHER	Placebo	Three Normal Saline IA injections of 3-8 mL at 1-week intervals.

Timeline

• Start date: 2016-07-01
• Primary completion: 2018-07-02
• Completion: 2018-08-30
• First posted: 2016-03-18
• Last updated: 2019-08-13
• Results posted: 2019-08-13

Locations

4 sites across 1 country: United States

Regulatory

• FDA-regulated device study